How pharmaceutical companies profit from drugs for rare diseases. The Conversation


Poletti-Hughes, J ORCID: 0000-0001-5959-2141 and Hughes, D ORCID: 0000-0001-8247-7459 (2016) How pharmaceutical companies profit from drugs for rare diseases. The Conversation. [Media]

This is the latest version of this item.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Media
Depositing User: Symplectic Admin
Date Deposited: 14 Feb 2020 09:06
Last Modified: 20 Jul 2023 14:55
Open Access URL: https://theconversation.com/how-pharmaceutical-com...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3070659

Available Versions of this Item

CORE (COnnecting REpositories)